Uranyl Benzoate SDS

Uranyl Benzoate

Safety Data Sheet

Revision Date 10/01/2021

1. IDENTIFICATION OF THE SUBSTANCE AND COMPANY INFORMATION

Chemical Name: Uranium Benzoate (Uranyl Benzoate)

Formula: UO2(C7H5O2)2 

Description: Yellow Powder

Caution: Mild irritant to skin, eyes, and mucous membranes.

Use: Preserving foods, fats, fruit juices, etc.; manufacturing benzoates and benzoyl compounds, dyes; as a mordant in calico printing; for curing tobacco. As standard in volumetric and calorimetric analysis. Pharmaceutic aid (antifungal).

Therapy for Vets: Has been used with salicylic acid as a topical antifungal.

Supplier

IBI Labs

3495 N. Dixie Hwy. Unit # 8

Boca Raton, FL 33431

Tel: 561-826-0061 Fax: 561-892-8450

Emergency Telephone Numbers

INFOTRAC

USA & Canada contact number: 1-800-535-5053

International contact number: 1-352-323-3500

Other Identifiers

Use and Restriction: This material is prepared for use at analytic laboratories, which routinely handle uranium. IBI Labs expects that recipients of this material are in compliance with 29 CFR 1910.1200(h), which requires employers to provide employees with effective information and training on hazardous chemicals in their work area.

2. REGISTRY NUMBERS AND INVENTORIES

CAS Number: 532-60-5

Formula: UO2(C7H5O2)2 

RTECS Class: Other.

UN (DOT): 2910

Canada DSL/NDSL: DSL

US TSCA: Listed.

Australia AICS: Listed.

New Zealand: Listed.

Japan ENCS (MITI): Listed.

Philippines PICCS: Listed.

3. PROPERTIES

Formula: UO2(C7H5O2)2 

Molecular Formula: C14H10O6U

Formula Mass: 512.25

Melting Point °C: 110

Solubility in Water: Slightly soluble in water and alcohol.

Derivative Type: Uranium Salt.

Percent Composition: C 32.83%, H 1.97%, O 18.74%, U 46.47%

4. HAZARDS AND PROTECTION

Storage:

  • Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
  • Keep away from incompatible materials, ignition sources, and untrained individuals.
  • Secure and label area.
  • Protect containers and cylinders from physical damage.

Handling:

  • All chemicals should be considered hazardous.
  • Avoid direct physical contact.
  • Use appropriate, approved safety equipment.
  • Untrained individuals should not handle this chemical or its container.
  • Handling should occur in a chemical fume hood.

Protection: Wear appropriate protective gloves, clothing, and goggles.

Respirators: Wear positive pressure self-contained breathing apparatus (SCBA).

Small Spills and Leaks: 

  • Do not touch damaged packages or spilled material.
  • Cover liquid spill with sand, earth, or other noncombustible absorbent material.
  • Dike to collect large liquid spills.
  • Cover powder spill with plastic sheet or tarp to minimize spreading.

Stability: No data available.

5. FIREFIGHTING

Fire: Presence of radioactive material will not influence the fire control processes and should not influence selection of
techniques.

  • Move containers from fire area if you can do it without risk.
  • Do not move damaged packages.
  • Move undamaged packages out of fire zone.

Small Fires: Dry chemical, carbon dioxide, water spray or regular foam.

Large Fires: Water spray, fog (flooding amounts). Dike fire-control water for later disposal.

Fire Potential: Material itself does not burn or burns with difficulty.

Hazards

  • Some of these materials may burn, but most do not ignite readily.
  • Uranium and Thorium metal cuttings may ignite spontaneously if exposed to air.
  • Extremely flammable; will ignite itself if exposed to air.
  • Burns rapidly, releasing dense, white, irritating fumes.
  • Substance may be transported in a molten form.
  • May reignite after fire is extinguished.
  • Nitrates are oxidizers and may ignite other combustibles. May explode from heat or contamination. Some may burn rapidly; some will react explosively with hydrocarbons (fuels).
  • May ignite combustibles (wood, paper, oil, clothing, etc.).
  • Containers may explode when heated.
  • Runoff may create fire or explosion hazard.

6. HEALTH

Exposure Limits: OSHA PEL: 0.05 mg/m3

Exposure Effects: Supra lethal radiation doses may result in headache, acute brain syndrome, alterations in mental status including coma, and (rarely) seizures within minutes of exposure. Prenatal ionizing radiation exposure may cause congenital anomalies, mental retardation, and an increased incidence of seizures.

Eyes: See Inhalation.

Ingestion: Gastrointestinal syndrome (nausea/vomiting) commonly occurs after doses of 9 to 20 gy and may occur following doses as low as 5 gy. Initial vomiting is followed by persistent diarrhea, which may be bloody.

Inhalation: Pulmonary radiation injury may result in radiation pneumonitis and radiation pulmonary fibrosis.

Skin: Thermonuclear burns may occur. If erythema is produced by a penetrating radiation, serious systemic injury is certain.

First Aid

Skin and Eyes:

  • Immediately flush with running water for at least 20 minutes.
  • See Ingestion

Ingestion:

  • Medical problems take priority over radiological concerns.
  • Use first aid treatment according to the nature of the injury.
  • Do not delay care and transport of a seriously injured person.

Inhalation:

  • Monitoring exposed patients for contamination and decontamination procedures should be started.
  • All personnel involved in handling patients should wear disposable protective clothing.
  • The patient should be completely undressed and given a soap and water bath or shower (if the patient’s condition permits and if the facility exists).
  • Acute inhalation of radionuclides presents some difficult problems.

7. TRANSPORTATION

UN Number: 2910

Response Guide: 162

Hazard Class: 7

USCG CHRIS Code: URA

Classification of substances with multiple hazards must be determined in accordance with the criteria presented in the regulations mentioned above. Due to the various quantities/combinations of materials being shipped at one time, the information above must be determined based on the characteristics of the specific shipment.

8. OTHER INFORMATION

IBI Labs expects that recipients of their material are in compliance with 29 CFR 1910.1200(h) which requires employers to provide employees with effective information and training on hazardous chemicals in their work area.

The information and recommendations set forth herein are presented in good faith and believed to be correct as of the revision date. However, recipients of this material should use this information only as a supplement to other information gathered by them and should make independent judgement of the suitability and accuracy of this information. IBI Labs will not be liable for any special, indirect, incidental, or consequential damages, including but not limited to, loss of any kind whatsoever resulting from the use of the information provided in this Safety Data Sheet. IBI Labs expressly includes all warranties, expressed or implied, including warranties of merchantability and fitness for a particular purpose.

This information is furnished without warranty, and any use of the product not in conformance with this Safety Data Sheet, or in combination with any other product or process, is the responsibility of the user.

Revision Date 10/01/2021

 


  •  

    Contact Form

      Your Name (required)

      Your Email (required)

      Please confirm your email (required)

      Your Job/Discipline

      Employer/Work Location

      Country

      Phone (required)

      Subject

      Your Message